Clinical Trials on AML/MDS in United Kingdom
Total 168929 results
-
TelikTerminatedMyelodysplastic Syndrome (MDS)United States
-
Actinogen MedicalAXIOM Real Time MetricsActive, not recruitingCognitive Impairment | Major Depressive Disorder | MDDAustralia, United Kingdom
-
H. Lee Moffitt Cancer Center and Research InstituteGlaxoSmithKlineTerminatedThrombocytopenia | Myelodysplastic Syndrome (MDS)United States
-
Tarix PharmaceuticalsTerminatedMyelodysplastic Syndrome (MDS)United States
-
University of Texas at AustinWithdrawn
-
Research Foundation for Mental Hygiene, Inc.Terminated
-
National Heart, Lung, and Blood Institute (NHLBI)RecruitingSevere Aplastic Anemia | Single Lineage Cytopenias, T-LGL | Hypoplastic MDSUnited States
-
Incyte CorporationTerminatedMDS (Myelodysplastic Syndrome)United States
-
Helsinn Healthcare SACompletedMyelodysplastic Syndrome | MDSUnited States
-
Astex Pharmaceuticals, Inc.CompletedMyelodysplastic Syndrome | MDSUnited States, Canada
-
Allievex CorporationEnrolling by invitationMPS III BUnited States, Germany, Turkey, United Kingdom, Colombia
-
Celgene CorporationCompletedLow- or Intermediate-1-risk Myelodysplastic Syndrome (MDS)United States
-
Seagen Inc.CompletedMyelodysplastic Syndrome (MDS)United States
-
National Heart, Lung, and Blood Institute (NHLBI)RecruitingParoxysmal Nocturnal Hemoglobinuria (PNH) | Severe Aplastic Anemia (SAA) | Hypo-Plastic Myelodysplastic Syndrome (MDS)United States
-
Peter L GreenbergAmgenCompletedMyelodysplastic Syndromes | Myelodysplastic Syndromes (MDS) | Blood CancerUnited States
-
Novartis PharmaceuticalsRecruitingMyelodysplastic Syndrome (MDS)United States
-
Alexion PharmaceuticalsCompletedMPS IIIB (Sanfilippo Syndrome)Spain, Netherlands, United Kingdom, United States, Brazil
-
M.D. Anderson Cancer CenterCompletedLeukemia | AML | MDS | CMLUnited States
-
National Heart, Lung, and Blood Institute (NHLBI)National Cancer Institute (NCI); National Institute of Allergy and Infectious... and other collaboratorsRecruitingLymphoma | Leukemia | Aplastic Anemia | Myelodysplastic Syndrome (MDS)United States
-
Senti BiosciencesRecruitingAML/MDS | CD33 Expressing Hematological Malignancies | FLT3 Expressing Hematological MalignanciesUnited States, Australia
-
M.D. Anderson Cancer CenterCelgeneCompleted
-
Daiichi Sankyo, Inc.CompletedAcute Myeloid Leukemia | Leukemia | AML | Myelodysplastic Syndrome | MDSUnited States, Georgia
-
Seattle Children's HospitalChildren's Healthcare of Atlanta; Pediatric Oncology Experimental Therapeutics...CompletedAML | Acute Leukemia of Ambiguous Lineage | ALL | Relapsed/Refractory AML | Relapsed/Refractory ALL | Secondary AML/MDSUnited States, Canada
-
Memorial Sloan Kettering Cancer CenterRecruitingNon-Hodgkin's Lymphoma | Myelodysplastic Syndromes (MDS) | Acute Lymphoblastic Leukemia (ALL) | Myeloproliferative Disorder | Acute Myelogenous Leukemia (AML) | Chronic Myelogenous Leukemia (CML)United States
-
AbbVieGenentech, Inc.Active, not recruitingMyelodysplastic Syndrome (MDS)United States, Australia, Austria, Belgium, Brazil, Canada, China, Czechia, France, Germany, Hungary, Israel, Italy, Japan, Korea, Republic of, Netherlands, Poland, Puerto Rico, Russian Federation, Spain, Taiwan, Turkey, United Kingdom
-
Massachusetts General HospitalTerminatedObstructed Defecation Syndrome (ODS)United States
-
TelikCompletedMyelodysplastic Syndrome (MDS)United States
-
University of California, San FranciscoDuke UniversityRecruitingWolman Disease | MPS IVA | Pompe Disease Infantile-Onset | Gaucher Disease, Type 2 | MPS VI | MPS I | Gaucher Disease, Type 3 | MPS II | Mps VIIUnited States
-
Onconova Therapeutics, Inc.CompletedMyelodysplastic Syndrome | MDS | Trisomy 8United States
-
BioMarin PharmaceuticalCompletedMPS VIUnited States, Australia, France, Brazil, Germany, Portugal, United Kingdom
-
Justin Watts, MDTakedaCompletedAML | Acute Myelogenous Leukemia | MDS | Advanced Myelodysplastic SyndromesUnited States
-
University of ChicagoTerminatedAcute Myeloid Leukemia (AML) | Myelodysplastic Syndrome (MDS)United States
-
Stanford UniversityNational Institutes of Health (NIH)CompletedMyelodysplastic Syndromes | Myeloproliferative Disorders | Myelodysplastic Syndromes (MDS) | Blood and Marrow Transplant (BMT) | Myeloproliferative Disorders (MPD)United States
-
East Kent Hospitals University NHS Foundation TrustCompletedCerebral Stroke | Chronic Brain Injury | MS (Multiple Sclerosis)United Kingdom
-
Everett MeyerNational Heart, Lung, and Blood Institute (NHLBI); National Institutes of Health...CompletedLymphoma, Non-Hodgkin | Acute Myeloid Leukemia | Acute Leukemia | Acute Myelogenous Leukemia | Chronic Myelogenous Leukemia | Myelodysplastic Syndromes (MDS) | Acute Lymphoblastic Leukemia (ALL) | Myeloid Leukemia, Chronic | Myeloproliferative SyndromeUnited States
-
BioMarin PharmaceuticalTerminatedMorquio A Syndrome | MPS IVA | Mucopolysaccharidosis IVAUnited Kingdom, United States, Germany
-
Orchard TherapeuticsRecruitingMPS-IH (Hurler Syndrome)Netherlands, United States, Italy, United Kingdom
-
BioMarin PharmaceuticalCompletedMorquio A Syndrome | MPS IVA | Mucopolysaccharidosis IVATaiwan, United States, Italy, United Kingdom
-
Allievex CorporationCompletedMucopolysaccharidosis Type IIIB | MPS III BUnited States, Taiwan, Spain, Colombia, Germany, United Kingdom, Turkey
-
St. Jude Children's Research HospitalNot yet recruitingLymphoma | Hematologic Malignancy | MDS | AML, Childhood | ALL, ChildhoodUnited States
-
Masonic Cancer Center, University of MinnesotaCompletedMyelodysplastic Syndrome (MDS) | Acute Myelogenous Leukemia (AML)United States
-
Abramson Cancer Center of the University of PennsylvaniaCompletedHigh Risk MDS or AML PatientsUnited States
-
ShireTerminatedSanfilippo Syndrome | Mucopolysaccharidosis (MPS)United States, United Kingdom, Spain, Germany, France, Italy, Netherlands
-
Sidney Kimmel Comprehensive Cancer Center at Johns...Bristol-Myers Squibb; BayerActive, not recruitingColon Cancer | Unresectable or Metastatic Microsatellite Stable (MSS) Solid Tumor Along With Microsatellite Stable (MSS) Colon CancerUnited States
-
Masonic Cancer Center, University of MinnesotaTerminatedAML | MDS | Leukemia, Lymphocytic, AcuteUnited States
-
Forma Therapeutics, Inc.RecruitingVery Low Risk, Low Risk, or Intermediate Risk MDS Per IPSS-RUnited States, France, Canada, Germany
-
Joanne Kurtzberg, MDMiltenyi Biomedicine GmbHCompletedHematologic Malignancy | Aplastic Anemia | Myelodysplastic Syndrome (MDS)United States
-
Synergy Health Concepts, Inc.UnknownVenous Irregularities, Flow and Perfusion in MS and Non-MS ParticipantsUnited States
-
Washington University School of MedicineCantex PharmaceuticalsCompletedAcute Myeloid Leukemia | Myelodysplastic Syndromes | AML | MDSUnited States
-
Allievex CorporationActive, not recruitingMucopolysaccharidosis Type IIIB | MPS III BGermany, United States, Turkey, United Kingdom, Colombia, Spain, Taiwan